United States 119th Congress Status: In Committee Bipartisan · 15 R · 12 D cosponsors

S 3345 — PBM Price Transparency and Accountability Act

Last action — Read twice and referred to the Committee on Finance.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced December 04, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 27 sponsors

    1 primary, 26 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (15 R · 12 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

9 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill amends existing Medicaid provisions related to pharmacy payments and oversight to improve transparency and accountability.

  • 42 U.S.C. 1396r-8(f)

    and → The Secretary shall conduct a survey of retail community pharmacy drug prices and applicable non-retail pharmacy drug prices to determine national average drug acquisition cost benchmarks (as such term is defined by the Secretary) as follows:

    This change specifies the Secretary's responsibility to survey pharmacy drug prices to establish national benchmarks.

  • 42 U.S.C. 1396r-8(f)(1)(B)

    subparagraph (A)(ii) → subparagraph (A)(iii)

    This updates references to reflect new ordering in the provisions of the law.

  • 42 U.S.C. 1396r-8(f)(1)(D)

    clauses (ii) and (iii) → The vendor must update the Secretary no less often than monthly on the survey prices for covered outpatient drugs. The vendor must differentiate, in collecting and reporting survey data, for all cost information collected, whether a pharmacy is a retail community pharmacy or an applicable non-retail pharmacy.

    This improves the requirements for vendors regarding how survey data are collected and reported.

  • 42 U.S.C. 1396r-8(f)(1)

    In order to meet the requirement of section 1902(a)(54), a State shall require that any retail community pharmacy or applicable non-retail pharmacy in the State that receives any payment, reimbursement, administrative fee, discount, rebate, or other price concession related to the dispensing of covered outpatient drugs to individuals receiving benefits under this title shall respond to surveys conducted under this paragraph.

    This mandates that pharmacies receiving certain payments must respond to surveys for transparency.

  • 42 U.S.C. 1396r-8(f)(1)

    Information on national drug acquisition prices obtained under this paragraph shall be made publicly available in a form and manner to be determined by the Secretary.

    This ensures that price information is made publicly available, enhancing transparency.

  • 42 U.S.C. 1396r-8(f)(1)(H)

    Subject to clauses (ii), (iii), and (iv), the Secretary shall enforce the provisions of this paragraph with respect to a pharmacy through the establishment of civil money penalties applicable to a retail community pharmacy or an applicable non-retail pharmacy.

    This establishes penalties for pharmacies that do not comply with new reporting requirements.

  • 42 U.S.C. 1396r-8(f)(1)(H)(iii)(I)

    A civil money penalty established under this subparagraph may be assessed with respect to each violation, and with respect to each non-compliant retail community pharmacy (including a pharmacy that is part of a chain) or non-compliant applicable non-retail pharmacy (including a pharmacy that is part of a chain), in an amount not to exceed $100,000 for each such violation.

    This clarifies that significant financial penalties can be applied for violations.

  • 42 U.S.C. 1396r-8(k)

    In the section → In this section

    This corrects the wording for clarity in definitions.

  • 42 U.S.C. 1396r-8(k)

    The term 'applicable non-retail pharmacy' means a pharmacy that is licensed as a pharmacy by the State and that is not a retail community pharmacy, including a pharmacy that dispenses prescription medications to patients primarily through mail and specialty pharmacies.

    This defines 'applicable non-retail pharmacy' to include specific types of pharmacies and exclude others.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 26 co-sponsors · 520 not signed on

Sponsors (1)

Co-sponsors (26)

Not signed on (520)

520 members have not signed on to this bill.

Show all 520 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 3345?
S 3345 is sponsored by Crapo, Mike (Republican), Wyden, Ron (Democratic), Grassley, Chuck (Republican), Bennet, Michael F. (Democratic), Cornyn, John (Republican), Warner, Mark R. (Democratic), Thune, John (Republican), Whitehouse, Sheldon (Democratic), Cassidy, Bill (Republican), Hassan, Margaret Wood (Democratic), Lankford, James (Republican), Cortez Masto, Catherine (Democratic), Daines, Steve (Republican), Smith, Tina (Democratic), Barrasso, John (Republican), Luján, Ben Ray (Democratic), Tillis, Thomas (Republican), Warnock, Raphael G. (Democratic), Blackburn, Marsha (Republican), Welch, Peter (Democratic), Marshall, Roger (Republican), Scott, Tim (Republican), Capito, Shelley Moore (Republican), Blunt Rochester, Lisa (Democratic), Young, Todd (Republican), Risch, James E. (Republican), and Heinrich, Martin (Democratic).
What is the current status of S 3345?
This bill is in committee in the Senate. Introduced December 04, 2025. It must pass committee before a floor vote.
Where can I track S 3345?
Track S 3345 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3345

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 3345

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →